Rosetta Genomics (NASDAQ: ROSG) announced that data highlighting its microRNA platform technology was published in Leukemia Research in an article ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE